Copilot
Your everyday AI companion
About 105.000 results
  1. Almost 73% of patients in the Opdivo group were alive, compared with 42% in the dacarbazine group. Median progression-free survival more than doubled among patients receiving Opdivo: just over five months compared with just over two months for dacarbazine.

    Opdivo Treatment for Malignant Melanoma - CancerConnect

    news.cancerconnect.com/melanoma/opdivo-treatment-for-malignant-melanoma
    news.cancerconnect.com/melanoma/opdivo-treatment-for-malignant-melanoma
    Was this helpful?
  2. People also ask
    Does Opdivo reduce the risk of melanoma returning after surgery?
    In the primary analysis at 7.8 months, patients who took OPDIVO had a 58% reduced risk of their melanoma returning after surgery compared to those who took placebo. At 1 year, 89% of patients who received OPDIVO did not have their melanoma return compared to 79% of patients who received placebo.

    Melanoma Adjuvant Treatment | OPDIVO® (nivolumab)

    opdivo.com
    How many melanoma patients received Opdivo & Yervoy?
    In an analysis of 945 previously untreated advanced melanoma patients, 314 received a combination of OPDIVO + YERVOY, 316 received OPDIVO alone, and 315 received YERVOY alone. Actor portrayals. OPDIVO is not approved for patients younger than 18 years of age.

    Metastatic Melanoma Therapies | OPDIVO® (nivolumab) + YERVOY® (i…

    opdivo.com
    Does Opdivo (nivolumab) help melanoma?
    Actor portrayals. OPDIVO® (nivolumab) was studied in a clinical trial of 790 people with Stage 2B or 2C melanoma, after having their melanoma completely removed by surgery. In the primary analysis at 7.8 months, patients who took OPDIVO had a 58% reduced risk of their melanoma returning after surgery compared to those who took placebo.

    Melanoma Adjuvant Treatment | OPDIVO® (nivolumab)

    opdivo.com
    How long does Opdivo last?
    Median survival is 72.1 months, or just over six years for those receiving the combination compared to 36.9 months, and for those treated with Opdivo alone. The combination may be justified in patients with BRAF mutations but not necessarily all patients. A more tailored approach to treatment is emerging. 1-7

    Opdivo - Yervoy Immunotherapy Prolongs Survival in ... - CancerConnect

    news.cancerconnect.com
    Feedback
  3. The New England Journal of Medicine
    https://www.nejm.org/doi/full/10.1056/NEJMoa1910836

    Five-Year Survival with Combined Nivolumab and Ipilimumab in …

    See results only from nejm.org
  4. Melanoma Research Alliance
    https://www.curemelanoma.org/blog/arti…

    Immunotherapy Survival Benefit for Advanced …

    WEBJul 28, 2021 · Patients treated with the combination of Opdivo + Yervoy demonstrated a progression free survival rate of 34% at 6.5 years, while patients treated with either Opdivo or Yervoy alone had a PFS of 29% …

    Explore further

    Yervoy Immunotherapy Prolongs Survival in Advanced …
    news.cancerconnect.com
    Combination of Immunotherapeutics Approved for …
    aacr.org
    Recommended to you based on what's popular • Feedback
  6. CancerConnect
    https://news.cancerconnect.com/melan…

    Opdivo - Yervoy Immunotherapy Prolongs Survival in …

    WEBSep 28, 2020 · Median survival is 72.1 months, or just over six years for those receiving the combination compared to 36.9 months, and for those treated with Opdivo alone. The combination may be justified in patients …

    Explore further

    How long does Opdivo prolong life and what’s its success …
    drugs.com
    Six-and-a-Half-Year Outcomes for - Business Wire
    businesswire.com
    Recommended to you based on what's popular • Feedback
  7. OPDIVO
    https://www.opdivo.com/metastatic-melanoma

    Metastatic Melanoma Therapies | OPDIVO® (nivolumab)

  8. Images of Opdivo Melanoma Survival

    bing.com/images
    See all images
  9. National Center for Biotechnology Information
    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7464656

    Real World Outcomes of Ipilimumab and Nivolumab in Patients …

    Tags:
    Ipilimumab Nivolumab Melanoma Nejm
    Ipilimumab Nivolumab Colorectal Tmb
  10. CURE
    https://www.curetoday.com/view/opdivo-alone-or-combined-with-yer…

    Opdivo Alone, or Combined with Yervoy Shows Continued Survival …

  11. OPDIVO
    https://www.opdivo.com/melanoma-adjuvant-treatment

    Melanoma Adjuvant Treatment | OPDIVO® (nivolumab)

    Tags:
    Nivolumab Adjuvant Melanoma
    Ipilimumab
  12. Food and Drug Administration (.gov)
    https://www.fda.gov/drugs/resources-information-approved-drugs/fda...

    FDA approves nivolumab for adjuvant treatment of Stage IIB/C …